期刊文献+

消化性溃疡复发危险因素的分析

下载PDF
导出
摘要 目的:探讨消化性溃疡的复发危险因素,为减少复发提供参考。方法:将213例消化性溃疡分为复发组(64例)与未复发组(149例)。比较两组患者在幽门螺旋杆菌阳性率、长期服用NSAIDs、不良生活饮食习惯(吸烟、饮酒)、精神紧张、复发季节、溃疡愈合质量等方面的差异。结果:复发组平均年龄58.9±12.5岁,高于未复发组的平均年龄41.3±9.8;复发组的幽门螺旋杆菌阳性率(92.2%)、长期服用NSAIDs(39.8%)、不良生活习惯(56.3%)均明显高于未复发组(74.8%、10.7%、24.2%);复合组愈合质量的S1期多于S2期,而未复发组的S2期多于S1期;复发组多发生于春秋季;复发组因精神因素复发的占9.38%,明显高于未复发组。结论:幽门螺旋杆菌感染、长期服用NSAIDs、不良生活习惯是消化道溃疡复发的重要危险因素。
作者 潘义斌
出处 《求医问药(下半月)》 2013年第8期20-21,共2页 Seek Medical and Ask The Medicine
  • 相关文献

参考文献4

二级参考文献25

  • 1胡伏莲,黄志烈,王菊梅,贾博琦,刘新光,谢鹏雁.幽门螺杆菌的根除及其在十二指肠溃疡愈合和复发中的作用[J].中华消化杂志,1996,16(2):106-107. 被引量:109
  • 2Miwa H, Sakaki N, Sugano K, et al. Recurrenl peplic ulcers in patients following successful helicobamer pylori eradication: A multicenter study of 4940 patients. Helicobaeter, 2004,9: 9-16.
  • 3Yamada T, David H, I.oren A, et al. Textbook of gastroenterology. 4th ed. Philadelphia: Lippincott Williams and Wilkins, 2003.
  • 4Ando T, Minami M, Mizuno T, el al. I.ong term follow up after eradication of helicobacter pylori with Omeprazole, Clarithromycin, and Tinidazole (OCT Regimen) in a Japanese population. Helicobacter,2005,10: 379-384.
  • 5Gisbert JP, Khorrami S, Carballo F, et al. Meta analysis: Helicobacter pylori eradication therapy vs. antisecretory noneradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther, 2004, 19: 617-629.
  • 6Gisbert JP. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol, 2005,100: 2083 2099.
  • 7Niv Y, Hazazi R. Helicobacter pylori recurrence in developed and developing countries: Meta-analysis of 13C-Urea breath test follow up after eradication. Helicobacter, 2008,13:56-61.
  • 8Manuel D, Cutler A, Goldstein J, et al. Decreasing prevalence combined whh increasing eradication of Helieobaeter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications. Aliment Pharmacol Ther,2007,25:1423-1427.
  • 9Chan K, Wong WV, Suen YB, et al. Combination of a cyclo oxygenase 2 inhibitor and a proton pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double blind, randomised trial. Lancet, 2007, 369: 1621-1626.
  • 10Nebiki H, Arakawa T, Higuchi K, et al. Quality of ulcer healing influences the relapse of gastric ulcers in humans. J Gastroenterol Hepatol,1997,12:109-114.

共引文献315

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部